BioCentury | Jul 31, 2020
Distillery Therapeutics

MAO-B, GABRA5 identified as astrocyte targets in subcortical stroke

...TSX:BHC; NYSE:BHC); Eldepryl selegiline from Orion Corp. (HSE:ORNAV; HSE:ORNBV) and Eisai Co. Ltd. (Tokyo:4523); Azilect rasagiline mesylate...
BioCentury | Jan 25, 2018

Takeda rides Denali’s ATV

...a delivery technology such as ATV. The pharma’s only other disclosed PD asset is Azilect rasagiline mesylate...
...Undisclosed Undisclosed Jan. 2016 Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) Japanese rights to Azilect rasagiline mesylate...
BioCentury | Jul 6, 2017
Clinical News

Takeda submits Japanese NDA for rasagiline to treat PD

...Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) submitted an NDA in Japan for Azilect rasagiline mesylate (TVP-1012) to treat...
...Agilect) (TVP-1012) Business: Neurology Julian Zhu Azilect rasagiline TVP-1012 H. Lundbeck A/S Takeda Pharmaceutical Co. Ltd. Teva Pharmaceutical Industries Ltd. Monoamine oxidase B (MAO-B) rasagiline mesylate...
BioCentury | Dec 14, 2015

Networking in Japan

...for multiple sclerosis drug Copaxone glatiramer acetate, and a 2014 deal for Parkinson's disease drug Azilect...
BioCentury | Aug 4, 2015
Company News

Teva buying majority stake in Immuneering

...far is Copaxone, with $1.1 billion in sales during 2Q15. Sales of Parkinson's disease drug Azilect...
BioCentury | Nov 10, 2014

Convert resurgence

...DKK3.19B ($542.9M) but came in above the Street's DKK3.14B estimate. Sales of Parkinson's disease drug Azilect...
BioCentury | Aug 11, 2014

Highlights of weekly biotech stock moves

...DKK3.448B ($631M) and were slightly below the Street's DKK3.452B estimate. Sales of Parkinson's disease drug Azilect...
BioCentury | Aug 7, 2014
Distillery Therapeutics

Indication: Neurology

...of PD. Teva Pharmaceutical Industries Ltd., H. Lundbeck A/S and Takeda Pharmaceutical Co. Ltd. market Agilect/Azilect...
BioCentury | Jun 30, 2014
Clinical News

Azilect rasagiline regulatory update

...FDA approved an sNDA for Azilect rasagiline to include use as an adjunct to dopamine agonists...
...Israel H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Azilect...
BioCentury | May 12, 2014

Zeroing in on immunity

...drug Ebixa memantine to DKK183M ($33.7M) due to generic competition. Sales of Parkinson's disease drug Azilect...
Items per page:
1 - 10 of 64